Orlistats mechanism creates predictable and often embarrassing side effects
For patients considering or currently using GLP-1 medications, knowing your personal headache history and genetic predispositions can support more meaningful conversations with your provider about monitoring, dosing adjustments, or alternative options
Effects of additive therapy with spironolactone on proteinuria in diabetic patients already on ACE inhibitor or ARB therapy: results of a randomized, placebo-controlled, double-blind, crossover trial
The Journal of Headache and Pain
In October, Eli Lillys Zepbound and Mounjaro were removed from the drug shortage list after nearly two years, though the FDA warned that there still may be intermittent localized supply disruptions. The removal from the listwhich bars outsourcing facilities from producing compounded versionsspurred the Outsourcing Facilities Association to file a lawsuit against the FDA, saying the move will deprive much of the public of access to a needed medicine. In response, the FDA agreed to reevaluate the situation and will allow compounding to continue during this period
GLP-1 receptors are located in areas of the brain that regulate both hunger and thirst